Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination
Sponsor: National Institute on Drug Abuse (NIDA)
A EARLY_PHASE1 clinical study on Pain, this trial is actively recruiting participants. The trial is conducted by National Institute on Drug Abuse (NIDA) and has accumulated 19 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
19 versions recorded-
Feb 2026 — Present [monthly]
Recruiting EARLY_PHASE1
-
Jan 2025 — Feb 2026 [monthly]
Recruiting EARLY_PHASE1
-
Sep 2024 — Jan 2025 [monthly]
Recruiting EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Recruiting EARLY_PHASE1
-
Jan 2024 — Jul 2024 [monthly]
Recruiting EARLY_PHASE1
▶ Show 14 earlier versions
-
Jul 2023 — Jan 2024 [monthly]
Recruiting EARLY_PHASE1
-
Jun 2023 — Jul 2023 [monthly]
Recruiting EARLY_PHASE1
-
Dec 2022 — Jun 2023 [monthly]
Recruiting EARLY_PHASE1
-
Apr 2022 — Dec 2022 [monthly]
Recruiting EARLY_PHASE1
Phase: PHASE1 → EARLY_PHASE1
-
Dec 2021 — Apr 2022 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Not Yet Recruiting PHASE1
-
Apr 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE1
-
Feb 2021 — Apr 2021 [monthly]
Not Yet Recruiting PHASE1
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting PHASE1
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE1
-
Sep 2020 — Nov 2020 [monthly]
Not Yet Recruiting PHASE1
-
May 2020 — Sep 2020 [monthly]
Not Yet Recruiting PHASE1
-
Mar 2020 — May 2020 [monthly]
Not Yet Recruiting PHASE1
-
Feb 2020 — Mar 2020 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute on Drug Abuse (NIDA)
- University of Florida
For direct contact, visit the study record on ClinicalTrials.gov .